In vivo preclinical studies confirmed the efficiency of such molecules in inducing NKG2D activation in NK cells, with subsequent enhancement of NK cell cytotoxic activity towards the respective antigen-presenting tumor cells [87]. Here, KLRK1 is linked to neoplasm.